COVID-19 Response

From the start of the SARS CoV-2 pandemic, the faculty from the Section of Infectious Diseases have played an instrumental part in organizing the response. This includes activities related to implementing appropriate PPE and infection control measures, designing testing algorithms, assessing optimal treatment strategies, establishing clinical trials, and designing a longitudinal cohort study and biorepository. In addition, our faculty have initiated a large number of research studies related to SARS CoV-2 and COVID-19. These include:

Basic and translational studies:
Antibody responses to COVID (Sagar)
Obesity and metabolic effects of COVID (Wetzler)
Salivary antibody response (Hochberg)
RNAsequencing signatures to predict poor outcomes (Marathe, Hochberg)
Epidemiology, modeling, and infection control:

Hospital transmission of COVID (Jacobson, Pierre)
Factors affecting persistence of virus and PCR detection (Pierre)
Impact of opioid use on COVD viral dynamics (Barocas)
Impact of obesity on antibody response (Hochberg)
Epidemiologic predictors of COVID outcomes (Assoumou)
Treatment response to immunomodulators (Sagar)
For additional details regarding the ID section response to COVID, please see http://www.bumc.bu.edu/id/covid-19-response/